Abstract
The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.
| Original language | English |
|---|---|
| Pages (from-to) | 417-418+425 |
| Journal | Dialysis and Transplantation |
| Volume | 17 |
| Issue number | 8 |
| Publication status | Published - 1988 |
Fingerprint
ASJC Scopus subject areas
- Nephrology
- Transplantation
Cite this
Diabetics in hemodialysis : Glycemic control by open-loop devices. / Spotti, D.; Slaviero, G.; La Rocca, E.; Quartagno, R.; Melandri, M.; Pozza, G.
In: Dialysis and Transplantation, Vol. 17, No. 8, 1988, p. 417-418+425.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Diabetics in hemodialysis
T2 - Glycemic control by open-loop devices
AU - Spotti, D.
AU - Slaviero, G.
AU - La Rocca, E.
AU - Quartagno, R.
AU - Melandri, M.
AU - Pozza, G.
PY - 1988
Y1 - 1988
N2 - The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.
AB - The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.
UR - http://www.scopus.com/inward/record.url?scp=0023726201&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023726201&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0023726201
VL - 17
SP - 417-418+425
JO - Dialysis and Transplantation
JF - Dialysis and Transplantation
SN - 0090-2934
IS - 8
ER -